Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Carboxypeptidase E (CPE) inhibits the secretion and activity of Wnt3a.

Oncogene·2016
Same author

[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.

Molecular psychiatry·2014
Same author

Carboxypeptidase E: a negative regulator of the canonical Wnt signaling pathway.

Oncogene·2012
Same author

Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity.

British journal of pharmacology·2011
Same author

Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner.

Oncogene·2008
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
Same journal

Dementia risk in middle-aged people linked to a blood protein.

Nature·2026
Same journal

Daily briefing: What's really happening with trust in science.

Nature·2026
查看所有相关文章

相关实验视频

Updated: Jun 25, 2026

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
13:18

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

该APC瘤抑制剂具有核出口功能.

R Rosin-Arbesfeld1, F Townsley, M Bienz

  • 1Laboratory of Molecular Biology, Cambridge, UK.

Nature
|September 13, 2000
PubMed
概括
此摘要是机器生成的。

大肠杆菌腺瘤多重症 (APC) 蛋白质的突变破坏了其核出口,导致β-catenin积累,并导致结直肠瘤的形成. 恢复APC的恢复方式

更多相关视频

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
08:12

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 12, 2014

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium
09:45

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium

Published on: May 18, 2021

相关实验视频

Last Updated: Jun 25, 2026

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
13:18

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells

Published on: December 29, 2012

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
08:12

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells

Published on: August 12, 2014

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium
09:45

Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium

Published on: May 18, 2021

科学领域:

  • 分子生物学分子生物学
  • 癌症研究 癌症研究
  • 细胞生物学 细胞生物学

背景情况:

  • 腺多样性大肠杆菌 (APC) 蛋白质突变在结直肠瘤中很普遍,通常导致截断的蛋白质.
  • 癌细胞中的突变APC稳定了β-catenin,促进了它的核转位,并作为转录的共同激活剂.
  • 通常情况下,APC通过Axin复合体和蛋白酶体通路促进β-catenin降解,这一过程的调节作用尚不清楚.

研究的目的:

  • 研究APC在β-catenin不稳定中的调控作用.
  • 确定APC离开核的机制及其对β-catenin的影响.
  • 确定APC核出口对其瘤抑制功能的重要性.

主要方法:

  • 在APC蛋白中识别和分析保存的核出口信号 (NES).
  • 在正常与APC突变癌细胞中APC核出口的比较.
  • 研究APC核出口与β-catenin核积累之间的相关性.

主要成果:

  • 在与APC突变集群区域相邻的3'中发现了高度保守的核出口信号.
  • 在APC突变癌细胞中,APC退出细胞核的能力丧失.
  • 有证据表明,APC核出口的丧失导致核中β-catenin的积累.

结论:

  • 通过保存的NES调解的APC核出口对其功能至关重要.
  • 癌细胞中APC核出口受损有助于β-catenin稳定和核积累.
  • 在结直肠癌中,APC退出细胞核的能力对于其瘤抑制活性至关重要.